Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?

Early data are now appearing relating to the measurement of biomarkers of acute kidney injury during renal replacement therapy. These data go some way in describing the clearance of these molecules during renal support. Understanding the potential clearance, or otherwise, of these proteins may lead...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostermann, Marlies, Forni, Lui G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075353/
https://www.ncbi.nlm.nih.gov/pubmed/25042547
http://dx.doi.org/10.1186/cc13933
_version_ 1782323328339410944
author Ostermann, Marlies
Forni, Lui G
author_facet Ostermann, Marlies
Forni, Lui G
author_sort Ostermann, Marlies
collection PubMed
description Early data are now appearing relating to the measurement of biomarkers of acute kidney injury during renal replacement therapy. These data go some way in describing the clearance of these molecules during renal support. Understanding the potential clearance, or otherwise, of these proteins may lead to directing our therapies in the future particularly with regard to cessation of renal support. We describe a recent study which has provided data that may aid in addressing this issue.
format Online
Article
Text
id pubmed-4075353
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40753532015-06-19 Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly? Ostermann, Marlies Forni, Lui G Crit Care Commentary Early data are now appearing relating to the measurement of biomarkers of acute kidney injury during renal replacement therapy. These data go some way in describing the clearance of these molecules during renal support. Understanding the potential clearance, or otherwise, of these proteins may lead to directing our therapies in the future particularly with regard to cessation of renal support. We describe a recent study which has provided data that may aid in addressing this issue. BioMed Central 2014 2014-06-19 /pmc/articles/PMC4075353/ /pubmed/25042547 http://dx.doi.org/10.1186/cc13933 Text en Copyright © 2014 Ostermann and Forni; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 The licensee has exclusive rights to distribute this article, in any medium, for 12 months following its publication. After this time, the article is available under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Ostermann, Marlies
Forni, Lui G
Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
title Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
title_full Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
title_fullStr Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
title_full_unstemmed Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
title_short Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
title_sort measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075353/
https://www.ncbi.nlm.nih.gov/pubmed/25042547
http://dx.doi.org/10.1186/cc13933
work_keys_str_mv AT ostermannmarlies measuringbiomarkersofacutekidneyinjuryduringrenalreplacementtherapywisdomorfolly
AT forniluig measuringbiomarkersofacutekidneyinjuryduringrenalreplacementtherapywisdomorfolly

Ejemplares similares